YAP1 and cholestasis: To comprehensively clarify how JCAD functions in the liver under pathophysiological conditions, the JCAD–Hippo–YAP signalling axis has been actively investigated on other liver disorders, including liver fibrosis33 and cholestasis in our ongoing studies, in which Hippo–YAP pathway is actively involved.